Cargando…
The Pharmacology of Pain Associated With the Monoiodoacetate Model of Osteoarthritis
The high incidence of osteoarthritis (OA) in an increasingly elderly population anticipates a dramatic rise in the number of people suffering from this disease in the near future. Because pain is the main reason patients seek medical help, effective pain management—which is currently lacking—is para...
Autor principal: | de Sousa Valente, João |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759799/ https://www.ncbi.nlm.nih.gov/pubmed/31619987 http://dx.doi.org/10.3389/fphar.2019.00974 |
Ejemplares similares
-
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
por: Pitcher, Thomas, et al.
Publicado: (2016) -
Sodium Monoiodoacetate Dose-Dependent Changes in Matrix Metalloproteinases and Inflammatory Components as Prognostic Factors for the Progression of Osteoarthritis
por: Bryk, Marta, et al.
Publicado: (2021) -
Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis
por: Mapp, P.I., et al.
Publicado: (2013) -
Characterisation of peripheral and central components of the rat monoiodoacetate model of Osteoarthritis
por: Lockwood, S.M., et al.
Publicado: (2019) -
Characterisation of a Peripheral Neuropathic Component of the Rat Monoiodoacetate Model of Osteoarthritis
por: Thakur, Matthew, et al.
Publicado: (2012)